Wouldn't that depend on whether the results of the p3 are positive / extent of efficacy...
- Forums
- ASX - By Stock
- PAR
- The After Story
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
16.9%
!
45.0¢

The After Story, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
45.0¢ |
Change
0.065(16.9%) |
Mkt cap ! $167.4M |
Open | High | Low | Value | Volume |
38.0¢ | 45.0¢ | 37.0¢ | $447.6K | 1.087M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 27190 | 44.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 17080 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 43262 | 0.425 |
1 | 1601 | 0.420 |
2 | 14400 | 0.415 |
2 | 2506 | 0.410 |
3 | 5639 | 0.405 |
Price($) | Vol. | No. |
---|---|---|
0.435 | 31594 | 3 |
0.440 | 22727 | 1 |
0.445 | 25710 | 2 |
0.450 | 24761 | 4 |
0.455 | 1601 | 1 |
Last trade - 12.10pm 03/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online